Outlook Therapeutics functions as a biopharmaceutical company utilizing advanced drug delivery science to reformulate proven therapeutics specifically for ophthalmology use. By securing formal regulatory approvals for customized ophthalmic formulations, the company aims to establish new standard-of-care options administered safely by retinal specialists for major degenerative eye diseases.